Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Impact Biomedical Inc. (IBO) had Normalized Pre-Tax Income of $-14.35M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.01M |
|
$-14.35M |
|
$0.01M |
|
$-0.00M |
|
$1.16M |
|
$-1.15M |
|
$-13.20M |
|
$-14.35M |
|
|
Normalized Pre-Tax Income |
$-14.35M |
$-14.35M |
|
$-14.35M |
|
$-14.35M |
|
$-14.35M |
|
$-1.15M |
|
$-0.86M |
|
12.19M |
|
12.19M |
|
$-1.18 |
|
$-1.18 |
|
| Balance Sheet Financials | |
$1.48M |
|
$0.01M |
|
$17.58M |
|
$19.06M |
|
$23.17M |
|
-- |
|
$3.27M |
|
$26.44M |
|
$-7.44M |
|
$-24.95M |
|
$-7.38M |
|
12.19M |
|
| Cash Flow Statement Financials | |
$-1.38M |
|
$0.00M |
|
$0.00M |
|
$2.00M |
|
$0.62M |
|
$-1.38M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.06 |
|
-- |
|
-- |
|
-- |
|
-3.03 |
|
-57.14% |
|
-16471.43% |
|
-16471.43% |
|
-- |
|
-205028.60% |
|
-204942.80% |
|
$-1.38M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.02 |
|
-- |
|
-- |
|
192.90% |
|
57.53% |
|
-75.30% |
|
194.47% |
|
$-0.61 |
|
$-0.11 |
|
$-0.11 |
|